Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Galmed Pharmaceuticals Ltd. buy StockNews.com

Start price
€6.40
16.11.25 / 50%
Target price
-
16.11.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 16.11.26. The prediction end date can be changed by StockNews_com at any time.
Performance without dividends (%)
Name 1w
Galmed Pharmaceuticals Ltd. -
iShares Core DAX® 0.760%
iShares Nasdaq 100 0.732%
iShares Nikkei 225® 1.025%
iShares S&P 500 -0.036%

Comments by StockNews_com for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren

Globus Medical (NYSE:GMED) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for GMED provided by MarketBeat

Stopped prediction by StockNews_com for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.42
11.03.23
-
11.03.24
-21.70%
12.03.24